Showing 1381-1390 of 1610 results for "".
- CMS Issues Preliminary Decision on Unique J Code for Avedro Photrexa Drug Formulationshttps://modernod.com/news/cms-issues-preliminary-decision-on-unique-j-code-for-avedro-photrexa-drug-formulations/2480101/Avedro announced that the Centers for Medicare and Medicaid Services (CMS) has issued a preliminary decision to establish a product specific Healthcare Common Procedure Coding System (HCPCS) J code for Photrexa drug formulations. Claims submitted with a product specific J code are generally proce
- Julie Schornack, OD, Named First Female President of Marshall B. Ketchum Universityhttps://modernod.com/news/julie-schornack-od-named-first-female-president-of-marshall-b-ketchum-university/2481585/Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution in Fullerton, California has introduced Julie A. Schornack, OD, MEd, as its next president to lead the university. Dr. Schornack is the first female p
- OD-OS Presents Navilas Laser System Pro 577s Navigated Retinal Laserhttps://modernod.com/news/od-os-presents-navilas-pro-as-an-affordable-entry-to-the-digital-ecosystem-of-navigated-laser/2478358/At the first virtual Euretina Congress, OD-OS presented the the Navilas Laser System 577s Pro for navigated retinal laser therapy. The Navilas Laser System 577s Pro supports precise and fast treatments of common retinal diseases, according to a company news release. It comes with the core trackin
- CooperVision’s Michele Andrews, OD, Wins 2019 Theia Excellence Award from Women in Optometryhttps://modernod.com/news/coopervisions-michele-andrews-od-wins-2019-theia-excellence-award-from-women-in-optometry/2477045/For her significant contributions to the advancement of the industry and optometric profession, Michele Andrews, OD, Senior Director of Professional and Academic Affairs, North America, CooperVision, has been named a 2019 recipient of Women in Optometry’s Theia Excellence Awards. Dr. And
- Alcon Names Carla Mack, OD, Global Head of Professional Affairs for Vision Carehttps://modernod.com/news/alcon-names-carla-mack-od-global-head-of-professional-affairs-for-vision-care/2476847/Alcon has announced that Carla Mack, OD, has been named Global Head, Professional Affairs. In her new role, Dr. Mack leads professional affairs within Alcon’s Global Vision Care Franchise, reporting to Andy Pawson, President and General Manager, Global Vision Care Franchise. As Global Head
- Johnson & Johnson Vision Appoints Carol Alexander, OD, Head, North America Vision Care Professional Relationshttps://modernod.com/news/johnson-johnson-vision-appoints-carol-alexander-od-head-north-america-vision-care-professional-relations/2479774/Carol Alexander, OD, has been appointed Head, North America Vision Care Professional Relations for Johnson & Johnson Vision. In this role, Carol will work to strengthen the relationship between Johnson & Johnson Vision and the optometric community in the US, w
- OD-OS Releases Software Update For the Computer-Guided Navilas 577s Laser Systemhttps://modernod.com/news/od-os-releases-software-update-for-the-computer-guided-navilas-577s-laser-system/2480112/OD-OS has released a comprehensive software update for the computer-guided Navilas 577s Laser System. New functionalities of software release 3.4 make the tissue-friendly treatment of retinal diseases using navigated microsecond laser pulses more intuitive, predictable, and reproducible, accordin
- Optometry and Vision Science Names New Editor-in-Chiefhttps://modernod.com/news/optometry-and-vision-science-announces-new-editor-in-chief/2481744/The American Academy of Optometry (AAO) announced that David Elliott, PhD, FCOptom, FAAO, is the new editor-in-chief of Optometry and Vision Science (OVS). Mr. Elliott succeeds Michael Twa, OD, PhD, FAAO, who is stepping down from the role after 7 years.
- J&J to Present New Data Demonstrating Superiority of Acuvue Oasys Max 1-Day for Astigmatism at AAOpthttps://modernod.com/news/jj-to-present-new-data-demonstrating-superiority-of-acuvue-oasys-max-1-day-for-astigmatism-at-aaopt/2484158/Johnson & Johnson announced new clinical data demonstrating significantly higher end-of-day comfort and stronger overall patient preference for the Acuvue Oasys Max 1-Day for Astigmatism contact lenses compared to Dailies Total1 for Astigmatism.
- J&J's Nipocalimab Significantly Improves Sjögren’s Disease Activity in a Phase 2 Studyhttps://modernod.com/news/jjs-nipocalimab-significantly-improves-sjogrens-disease-activity-in-a-phase-2-study/2482323/Johnson & Johnson announced that patients treated with nipocalimab demonstrated statistically significant (P=0.002) and clinically meaningful improvement in ClinESSDAIa score versus placebo at 24 weeks compared to baseline (primary endpoint) in the phase 2 DAHLIAS dose-rang